Prestalia
Product Images NDC 72931-010

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Prestalia (NDC 72931-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Adhera Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1.a (Adhera 01)

Figure 1.a (Adhera 01)
This text appears to be a graphical representation of blood pressure (SBP) levels and medications used to control it. The graph shows different medication dosages along with corresponding blood pressure readings in mmHg. The text provides information about the maximum recommended SBP level for medication use, which is less than 140 mmHg.*
FDA Label Image

Figure 1.b (Adhera 02)

Figure 1.b (Adhera 02)
The text is a chart that displays blood pressure readings for a medication called Prestalia 14/10 mg. The chart shows that the medication's recommended blood pressure is less than 130 mmHg. The chart also displays the baseline SBP (mmHg) for the medication.*
FDA Label Image

Figure 1.c (Adhera 03)

Figure 1.c (Adhera 03)
This appears to be a blood pressure medication label or prescription. The medication is called Prestalia, which contains a combination of Amlodipine (10mg) and Perindopril erbumine (16mg). The text shows a graph that possibly represents the effect of the medication on diastolic blood pressure (DBP). The medication is likely intended to lower the DBP, as indicated by the text "DBP <90 mmHg" and the decreasing trend in DBP values in the graph.*
FDA Label Image

Figure 1.d (Adhera 04)

Figure 1.d (Adhera 04)
The text is describing the blood pressure levels (DBP) and the dosage of a medication called Prestalia (14/10 mg) containing Perlindopril Erbumine (16 mg). It also includes a graph with different values of baseline DBP (mmHg) ranging from 920 to 120.*
FDA Label Image

Chemical Structure (Adhera 05)

FDA Label Image

Chemical Structure (Adhera 06)

FDA Label Image

Principal Display Panel (3.5 mg/2.5 mg Tablet Bottle Label)

Principal Display Panel (3.5 mg/2.5 mg Tablet Bottle Label)
This is a description of a medication named Prestalia, which comes in the form of tablets. Each tablet contains 2.38 mg of perindopril (35 mg of perindopril arginine) and 2.5 mg of amlodipine (3.47 mg of amlodipine besylate). Dosage and administration information is provided in accompanying literature. The tablets should be stored at room temperature and protected from moisture. They are manufactured by Patheon Pharmaceuticals in the US and marketed by Aclhera Therapeutics. The medication is a product of France and comes in bottles of 90 tablets. The text also includes a warning to keep the medication out of reach of children.*
FDA Label Image

Principal Display Panel (7 mg/5 mg Tablet Bottle Label)

FDA Label Image

Principal Display Panel (14 mg/10 mg Tablet Bottle Label)

Principal Display Panel (14 mg/10 mg Tablet Bottle Label)
Each tablet contains porndepilas, perindopril arginine, amiodipine, and amlodipine besylate. It is a medication used for the treatment of hypertension. The dosage and administration information is mentioned on the accompanying literature. It should be stored at a controlled room temperature and protected from moisture. The product is manufactured by Paragon Pharmaceuticals, Inc. and marketed by Adnera Therapeutics, Inc. It is recommended to keep the product out of reach of children. Product of France.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.